ベトナムのメディカルニュートリション市場2020年-2027年:製品別(乳児栄養、非経口栄養、経腸栄養)、用途別、流通チャネル別、エンドユーザー別

【英語タイトル】Vietnam Medical Nutrition Market by Product (Infant Nutrition, Parenteral Nutrition, and Enteral Nutrition), Application (Diabetes, Cancer, Gastrointestinal Diseases, Chronic Kidney Disease, Chronic Liver Disease, Intensive Care, Chronic Obstructive Pulmonary Disease, and Others), Distribution Channel (Hospital Pharmacies, Drug Store & Retail Pharmacies, and Online Pharmacies), and End User (Private Hospitals, Public Hospitals, and Homecare): Opportunity Analysis and Industry Forecast, 2020–2027

Allied Market Researchが出版した調査資料(ALD21FB074)・商品コード:ALD21FB074
・発行会社(調査会社):Allied Market Research
・発行日:2020年12月
・ページ数:102
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:ベトナム
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,829 ⇒換算¥418,692見積依頼/購入/質問フォーム
5 UserUSD2,919 ⇒換算¥432,012見積依頼/購入/質問フォーム
Enterprise UserUSD4,070 ⇒換算¥602,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Allied Market Research社の本調査レポートでは、ベトナムのメディカルニュートリション市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、製品別(乳児栄養、非経口栄養、経腸栄養)分析、用途別(糖尿病、癌、胃腸疾患、慢性腎臓病、慢性肝臓病)分析、流通チャネル別(病院薬局、ドラッグストア・小売薬局、オンライン薬局)分析、エンドユーザー別(私立病院、公立病院、在宅治療)分析、企業情報などを掲載しています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・ベトナムのメディカルニュートリション市場規模:製品別(乳児栄養、非経口栄養、経腸栄養)
・ベトナムのメディカルニュートリション市場規模:用途別(糖尿病、癌、胃腸疾患、慢性腎臓病、慢性肝臓病)
・ベトナムのメディカルニュートリション市場規模:流通チャネル別(病院薬局、ドラッグストア・小売薬局、オンライン薬局)
・ベトナムのメディカルニュートリション市場規模:エンドユーザー別(私立病院、公立病院、在宅治療)
・企業情報

The Vietnam medical nutrition market generated $270.16 million in 2019, and is projected to reach $373.05 million by 2027, growing at a CAGR of 5.1% from 2020 to 2027.

Medical nutrition is also referred as clinical nutrition. It means the nutrition required for the management of patients, including not only outpatients at clinics, but also inpatients in hospitals. It includes primarily the scientific fields of nutrition and dietetics. Furthermore, medical nutrition therapy is a specialized, dietician-developed regimen used to treat chronic illness or other medical condition.

The Vietnam medical nutrition market is expected to register substantial growth in the near future, owing to rise in incidence of chronic diseases and surge in geriatric population across Vietnam. However, lack of awareness of nutrition problems among Vietnamese is projected to hamper the market growth during the forecast period. Conversely, rise in medical tourism in Vietnam is expected to offer remunerative opportunities for market players.

The Vietnam medical nutrition market is segmented on the basis of product, application, distribution channel, and end user. By product, the market is categorized into infant nutrition, parenteral nutrition, and enteral nutrition. The parenteral nutrition is further segmented into dextrose based products, fat based products, and additives based products. The enteral nutrition is further segmented into standardized, semi elemental, and specialized. By application, the market is categorized into diabetes, cancer, gastrointestinal diseases, chronic kidney disease, chronic liver disease, intensive care, chronic obstructive pulmonary disease, and others. By distribution channel, the market is classified into hospital pharmacies, drug store & retail pharmacies, and online pharmacies. By end user, the market is segmented into private hospitals, public hospitals, and homecare.

KEY BENEFITS FOR STAKEHOLDERS

 This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.
 An in-depth analysis of country is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate country-specific plans.
 A comprehensive analysis of the factors that drive and restrain the growth of the Vietnam medical nutrition market is provided.

KEY MARKET SEGMENTS
• By Product
o Infant Nutrition
o Parenteral Nutrition
 Dextrose-based Products
 Fat-based Products
 Additives-based Products
o Enteral Nutrition
 Standardized
 Semi Elemental
 Specialized

• By Application
o Diabetes
o Cancer
o Gastrointestinal Diseases
o Chronic Kidney Disease
o Chronic Liver Disease
o Intensive Care
o Chronic Obstructive Pulmonary Disease
o Others

• By Distribution Channel
o Hospital Pharmacies
o Drug Store & Retail Pharmacies
o Online Pharmacies

• By End User
o Private Hospitals
o Public Hospitals
o Homecare

KEY MARKET PLAYERS
• Abbott Laboratories
• Baxter International Inc.
• B. Braun Melsungen AG.
• Fresenius SE & Co. KGaA.
The other players in the value chain include (profiles not included in the report):
• Danone Nutricia
• Mead Johnson Nutrition Co.
• Nestle S.A.
• Bayer AG
• Pfizer Inc.
• Sanofi S.A.
• GlaxoSmithKline Plc
• Perrigo Company Plc.

❖ レポートの目次 ❖

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Top player positioning
3.4.Porter’s five forces analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in incidence of chronic diseases
3.5.1.2.Surge in geriatric population across Vietnam

3.5.2.Restraint

3.5.2.1.Lack of awareness of nutrition problems among Vietnamese

3.5.3.Opportunity

3.5.3.1.Rise in medical tourism in Vietnam

3.6.List of key brands, by product type
3.7.List of key players, by product type
3.8.Average selling price, by product type
3.9.Vietnam key cities data
3.10.Impact analysis of COVID-19 on market

3.10.1.Overview
3.10.2.Impact on the market

CHAPTER 4:VIETNAM MEDICAL NUTRITION MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Infant Nutrition

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast

4.3.Parenteral Nutrition

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type

4.3.2.1.Dextrose based Products

4.3.2.1.1.Market size and forecast

4.3.2.2.Fat based Products

4.3.2.2.1.Market size and forecast

4.3.2.3.Additives based Products

4.3.2.3.1.Market size and forecast

4.3.3.Market size and forecast

4.4.Enteral Nutrition

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by type

4.4.2.1.Standardized

4.4.2.1.1.Market size and forecast

4.4.2.2.Semi Elemental

4.4.2.2.1.Market size and forecast

4.4.2.3.Specialized

4.4.2.3.1.Market size and forecast

4.4.3.Market size and forecast

CHAPTER 5:VIETNAM MEDICAL NUTRITION MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Diabetes

5.2.1.Market size and forecast

5.3.Cancer

5.3.1.Market size and forecast

5.4.Gastrointestinal Diseases

5.4.1.Market size and forecast

5.5.Chronic Kidney Disease

5.5.1.Market size and forecast

5.6.Chronic Liver Disease

5.6.1.Market size and forecast

5.7.Intensive Care

5.7.1.Market size and forecast

5.8.Chronic Obstructive Pulmonary Disease

5.8.1.Market size and forecast

5.9.Others

5.9.1.Market size and forecast

CHAPTER 6:VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospital Pharmacies

6.2.1.Market size and forecast

6.3.Drug Store & Retail Pharmacies

6.3.1.Market size and forecast

6.4.Online Pharmacies

6.4.1.Market size and forecast

CHAPTER 7:VIETNAM MEDICAL NUTRITION MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Private Hospitals

7.2.1.Market size and forecast

7.3.Public Hospitals

7.3.1.Market size and forecast

7.4.Homecare

7.4.1.Market size and forecast

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES

8.1.1.Product portfolio
8.1.2.Business performance
8.1.3.Key strategic moves and developments

8.2.B. BRAUN MELSUNGEN AG

8.2.1.Product Portfolio
8.2.2.Business performance

8.3.BAXTER INTERNATIONAL INC.

8.3.1.Product Portfolio
8.3.2.Business performance

8.4.FRESENIUS SE & CO. KGAA

8.4.1.Product portfolio
8.4.2.Business performance

LIST OF TABLES

TABLE 01.LIST OF KEY BRANDS, BY PRODUCT TYPE
TABLE 02.LIST OF KEY PLAYERS, BY PRODUCT TYPE
TABLE 03.AVERAGE SELLING PRICE, BY PRODUCT TYPE
TABLE 04.VIETNAM KEY CITIES DATA
TABLE 05.VIETNAM MEDICAL NUTRITION MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 06.VIETNAM MEDICAL NUTRITION MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.VIETNAM MEDICAL NUTRITION MARKET FOR ENTERAL NUTRITION, BY TYPE, 2019–2027 ($MILLION)
TABLE 08.VIETNAM MEDICAL NUTRITION MARKET, BY APPLICATION 2019-2027($MILLION)
TABLE 09.VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 10.VIETNAM MEDICAL NUTRITION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 11.ABBOTT: PRODUCT PORTFOLIO
TABLE 12.B. BRAUN: PRODUCT PORTFOLIO
TABLE 13.FRESENIUS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.TOP INVESTMENT POCKETS, 2019
FIGURE 02.TOP PLAYER POSITIONING, 2019
FIGURE 03.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 04.HIGH BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE THREAT OF SUBSTITUTION
FIGURE 06.MODERATE THREAT OF NEW ENTRANT
FIGURE 07.HIIGH COMPETITIVE RIVALRY
FIGURE 08.MEDICAL NUTRITION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 09.INFANT NUTRITION MARKET, 2019–2027 ($MILLION)
FIGURE 10.PARENTERAL NUTRITION MARKET FOR DEXTROSE BASED PRODUCTS, 2019-2027 ($MILLION)
FIGURE 11.PARENTERAL NUTRITION MARKET FOR FAT BASED PRODUCTS, 2019-2027 ($MILLION)
FIGURE 12.PARENTERAL NUTRITION MARKET FOR ADDITIVES BASED PRODUCTS, 2019-2027 ($MILLION)
FIGURE 13.PARENTERAL NUTRITION MARKET, 2019–2027 ($MILLION)
FIGURE 14.ENTERAL NUTRITION MARKET FOR STANDARDIZED, 2019-2027 ($MILLION)
FIGURE 15.ENTERAL NUTRITION MARKET FOR SEMI ELEMENTAL, 2019-2027 ($MILLION)
FIGURE 16.ENTERAL NUTRITION MARKET FOR SPECIALIZED, 2019-2027 ($MILLION)
FIGURE 17.ENTERAL NUTRITION MARKET, 2019–2027 ($MILLION)
FIGURE 18.VIETNAM MEDICAL NUTRITION MARKET FOR DIABETES, 2019–2027 ($MILLION)
FIGURE 19.VIETNAM MEDICAL NUTRITION MARKET FOR CANCER, 2019–2027 ($MILLION)
FIGURE 20.VIETNAM MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, 2019–2027 ($MILLION)
FIGURE 21.VIETNAM MEDICAL NUTRITION MARKET FOR CHRONIC KIDNEY DISEASE, 2019–2027 ($MILLION)
FIGURE 22.VIETNAM MEDICAL NUTRITION MARKET FOR CHRONIC LIVER DISEASE, 2019–2027 ($MILLION)
FIGURE 23.VIETNAM MEDICAL NUTRITION MARKET FOR INTENSIVE CARE, 2019–2027 ($MILLION)
FIGURE 24.VIETNAM MEDICAL NUTRITION MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019–2027 ($MILLION)
FIGURE 25.VIETNAM MEDICAL NUTRITION MARKET FOR OTHERS, 2019–2027 ($MILLION)
FIGURE 26.VIETNAM MEDICAL NUTRITION MARKET FOR HOSPITAL PHARMACIES, 2019–2027 ($MILLION)
FIGURE 27.VIETNAM MEDICAL NUTRITION MARKET FOR DRUG STORE & RETAIL PHARMACIES, 2019–2027 ($MILLION)
FIGURE 28.VIETNAM MEDICAL NUTRITION MARKET FOR ONLINE PHARMACIES, 2019–2027 ($MILLION)
FIGURE 29.VIETNAM MEDICAL NUTRITION MARKET FOR PRIVATE HOSPITALS, 2019–2027 ($MILLION)
FIGURE 30.VIETNAM MEDICAL NUTRITION MARKET FOR PUBLIC HOSPITALS, 2019–2027 ($MILLION)
FIGURE 31.VIETNAM MEDICAL NUTRITION MARKET FOR HOMECARE, 2019–2027 ($MILLION)
FIGURE 32.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.ABBOTT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.ABBOTT: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 35.NET SALES, 2017–2019 ($MILLION)
FIGURE 36.B. BRAUN: NET SALES BY DIVISION, 2019 (%)
FIGURE 37.B. BRAUN: NET SALES BY REGION, 2019 (%)
FIGURE 38.NET SALES, 2017–2019 ($MILLION)
FIGURE 39.BAXTER: REVENUE SHARE BY BUSINESS SEGMENT, 2019 (%)
FIGURE 40.BAXTER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.FRESENIUS: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.FRESENIUS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43.FRESENIUS: REVENUE SHARE BY PRODUCT SEGMENT, 2019 (%)
FIGURE 44.FRESENIUS: REVENUE SHARE BY REGION, 2019(%)

★調査レポート[ベトナムのメディカルニュートリション市場2020年-2027年:製品別(乳児栄養、非経口栄養、経腸栄養)、用途別、流通チャネル別、エンドユーザー別] (コード:ALD21FB074)販売に関する免責事項を必ずご確認ください。
★調査レポート[ベトナムのメディカルニュートリション市場2020年-2027年:製品別(乳児栄養、非経口栄養、経腸栄養)、用途別、流通チャネル別、エンドユーザー別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆